Navigation Links
Peregrine in Medical News

Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections

--PS-Targeting AntibodiesMay Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal Viral Infections in Preclinical Models-- --Data C...

Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting

- Bavituximab Appeared Generally Safe and Well Tolerated at All Doses Tested - - Signs of Anti-viral Activity Seen at All Dose Levels - - Exploratory Analysis of Cytokine Profile Following Treatment Supports Proposed Immunomodulatory Mechanism ...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009

...USTIN, Calif. , July 14 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), today ann...addition to manufacturing revenues, during FY 2009 peregrine generated revenues from services provided under it...percent in FY 2009 compared to FY 2008. peregrine reported a consolidated net loss of $3,609,000, or...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

...Nabi Biopharmaceuticals Starts Proof-Of-Concept Trial for Civacir II-60 peregrine Announces Positive Results for Bavituximab II-60 Jenken to Commence Pha...66 Roche Inks Licensing Deal with Novartis and Ortho-Clinical II-66 peregrine Opens Subsidiary in China II-66 InterMune Completes Production Mileston...

Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial

... TUSTIN, Calif., June 30 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno...n reached even at the highest planned dose level. peregrine has now begun designing additional bavituximab can... posted at www.peregrineinc.com . About peregrine Pharmaceuticals ...

Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform

... TUSTIN, Calif., June 24 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today repo...ty of Texas System and is exclusively licensed to peregrine Pharmaceuticals. 1. M Jennewein, M Lewis, D Z... posted at www.peregrineinc.com . About peregrine Pharmaceuticals ...

ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer

... TUSTIN, Calif., June 10 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno... posted at www.peregrineinc.com . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants

... stock alerts for free by visiting BeaconEquity.com/m . Today's Stock Alerts include: Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI ), peregrine Pharmaceuticals Inc. (Nasdaq: PPHM ), Biogen Idec Inc. (Nasdaq: BIIB ), Genzyme Corp. (Nasdaq: GENZ ), Celgene Corp. (Nasdaq: CELG ) and Gilea...

Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program

... TUSTIN, Calif., May 28 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical...ls, visit www.clinicaltrials.gov . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule

...TUSTIN, Calif., March 25 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today annou...it has received a letter from NASDAQ that provides peregrine with an additional three months to regain compliance with the minimum bid price rule. peregrine now has until October 26, 2009 to regain complianc...
Peregrine in Medical Technology

Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies

OSLO, Norway, April 28 /PRNewswire/ -- Affitech AS, the human antibody therapeutics company, announced today that preclinical data on two fully human anti-PS (phosphatidylserine) antibodies were presented by its collaboration partner Peregrine Pharmaceuticals at the 100th Annual Meeting of the...

New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models

-- Data Presented at Anti-Angiogenesis Conference Shows R84, the Selective Human Anti-VEGF Antibody Developed by Peregrine in Association with Affitech, Is Equivalent to Avastin in Inhibiting Growth of Established Tumors in a Preclinical Breast Cancer Model -- -- R84 Is Being ...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - Affitech AS, the human antibody therapeutics company announced today that Peregrine Pharmaceuticals, Inc. reported positive in vivo test results of R3, a fully human monoclonal antibody developed by Affitech, in a pancreatic cancer model at the recently...

Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials

... TUSTIN, Calif., June 3 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today high... posted at www.peregrineinc.com . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients

... TUSTIN, Calif., May 4 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today annou...nced solid cancers is also continuing. About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model

...TUSTIN, Calif., April 22 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical...hia (PA): AACR; 2009. Abstract nr 5463 About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

...TUSTIN, Calif., April 21 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinica... Medical Center in Dallas, a scientific advisor to peregrine and co-author of one of the AACR presentations. "...f preclinical studies by a team of scientists from peregrine Pharmaceuticals and Affitech A/S used a fully huma...

Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial

...TUSTIN, Calif., April 20 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), today ann...d solid cancers is also continuing. About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial

...tion Criteria in Solid Tumors (RECIST) criteria. peregrine president and CEO, Steven W. King noted, "We are v...advanced solid cancers is also continuing. About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer

... - peregrine Achieves Milestone as Third Phase II Trial in Its ...CH) and Good Clinical Practices (GCP) standards. peregrine recently reported that a Phase II trial assessing ...advanced solid cancers is also continuing. About peregrine Pharmaceuticals ...

More>>

Peregrine in Biological News

Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies

... Medical Center in Dallas, a scientific advisor to peregrine and co-author of one of the AACR presentations. "...f preclinical studies by a team of scientists from peregrine Pharmaceuticals and Affitech A/S used a fully huma...argeting antibodies," said Dr. Monica Friedrich, a peregrine research scientist and lead author of the study. ...

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

... TUSTIN, Calif., November 23, 2008 -- peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the compa...

KAUST and IBM to build 1 of the fastest and most powerful supercomputers

... computational sciences, and contribute to the further development of a knowledge-based society in Saudi Arabia. Shaheen is the Arabic word for the peregrine falcon, a bird which can reach dive speeds of up to 213 miles (or 342 kilometers) per hour. Similarly, the 16-rack Blue Gene/P System , capable of 2...

Recovery efforts not enough for critically endangered Asian vulture

...ersity of North Texas in Denton. "We just need to get diclofenac out of the environment and more birds into protection before it is too late." The peregrine Fund, a organization that works to conserve birds of prey in nature, is trying to prevent the birds' extinction, but it's an effort that requires mone...

Endangered shortnose sturgeon saved in Hudson River

...cetera," said Bain. Since 1966 when the federal government started identifying threatened species, only 16, including the American alligator, American peregrine falcon and brown pelican, have recovered. "Recovery is very rare," said Bain, who has been monitoring the shortnose sturgeon's population since the mi...
Peregrine in Biological Technology

Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program

- Agency Confirms Its Continuing Interest in Peregrine's Anti-PS Technology for Biodefense Applications - TUSTIN, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical stage biopharmaceutical company developing monoclonal antib...

Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference

... TUSTIN, Calif., July 23 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno...www.jesuplamontconferences.com . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

...RSHOLM, Denmark, July 22 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) and Affite...elopment and potential product commercialization. peregrine will receive an upfront payment, research fees and...ally totaling in the double-digit millions (US$). peregrine will also receive royalties on any future sales an...

Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference

...ave such a diversified group of innovative biotech companies presenting at our conference." Some of the companies presenting on July 30th include peregrine Pharmaceuticals (Nasdaq: PPHM ), Cytori Therapeutics (Nasdaq: CYTX ), NovaBay Pharmaceuticals (Amex: NBY ), Nabi Biopharmaceuticals (Nasdaq: N...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...on CB7630 in Patients with Prostate Cancer II-54 Ambrilia Unveils Results of PCK3145 in Patients with Metastatic Prostate Cancer II-54 peregrine Pharmaceuticals Reveals Pre-Clinical Data on Bavituximab in Prostate Cancer II-54 Cell Genesys Reveals Data of GVAX Immunotherapy for Treatmen...

Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine

... TUSTIN, Calif., July 1 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno.... Parseghian, Ph.D., senior director of R&D at peregrine and senior author of the new publication, commente...umber 1 638 989. It was developed by inventors at peregrine and the Paul Scherrer Institute in Switzerland, wh...

Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

... TUSTIN, Calif., June 16 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today repo...als, visit www.clinicaltrials.gov . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting

...d TUSTIN, Calif., June 1 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno...n or treatment discontinuation. Separately, peregrine reported that researchers will present data at ASC...vel 2, West Hall C Abstract No: 1080 About peregrine Pharmaceuticals ...

Clinical Data on Peregrine's Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting

... TUSTIN, Calif., May 27 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical...omepage at www.peregrineinc.com . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial

...TUSTIN, Calif., April 27 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), today ann...d solid cancers is also continuing. About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...
Peregrine in Biological Dictionary

Genetic diversity

...ans a greater ability for ... World Resources Institute: Genetic Diversity ... Statement on Genetic Diversity . This is a statement from the peregrine Fund on genetic diversity . Shattering ... Genetic Diversity - Research - Harvard Malaria Initiative - Harvard School of Public Health ... U...
Other Tags
(Date:8/29/2014)... (PRWEB) August 29, 2014 ALS, more commonly ... that damages the motor neurons in the brain and spinal ... the nerve cells controlling movement are harmed, which causes the ... this leads to death. , ALS is a disease that ... as many as 30,000 Americans have the disease at any ...
(Date:8/29/2014)... Canadian Healthy Vending , the largest ... annual survey of its 200 operators from every region ... that appeal to Canadian consumer seeking refreshment at healthy ... top five selling healthy snacks and top five selling ... issue for consumers, employers, and families. Everyone wants to ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Until now, ... (relational tables) or unstructured data (document stores). SQL products ... products have basically managed the wide assortment of unstructured ... to work with Big Data is with a NoSQL ... the various aspects of all Big Data issues. ...
(Date:8/28/2014)... August 29, 2014 VPS (Virtual ... physical server computer into many servers, each of ... on someone’s own dedicated computer. Top10BestSEOHosting.com has recently ... that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ), Bluehost and IX ... in 2014. , The IT manager of Top10BestSEOHosting.com ...
(Date:8/28/2014)... York (PRWEB) August 29, 2014 New ... they will be traveling around the country to Log ... final show in November. The New Energy Works team ... their timber frame design and build expertise, project images, ... Drake Ambrosino , New Energy Works’ Mid-West Representative, will ...
Breaking Medicine News(10 mins):Health News:Charity Event to Raise Awareness and Donations for the ALS Foundation 2Health News:Survey Results: What Products Do Canadians Want in Their Healthy Vending Machines? 2Health News:Survey Results: What Products Do Canadians Want in Their Healthy Vending Machines? 3Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 3Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 4Health News:Top10BestSEOHosting.com Announces The Best Three VPS Hosting Suppliers 2Health News:New Energy Works Timberframers Prepares to Exhibit Timber Framing at Autumn Trade Shows 2Health News:New Energy Works Timberframers Prepares to Exhibit Timber Framing at Autumn Trade Shows 3
(Date:8/27/2014)... Using functional near infrared spectroscopy (fNIRS), Kessler Foundation ... people with multiple sclerosis (MS) and healthy controls. ... brain activation was studied using fNIRS while participants ... cognition using functional near infrared spectroscopy (fNIRS) in ... by Brain Imaging and Behavior . Authors ...
(Date:8/27/2014)... 400 million years ago a group of fish began exploring ... and mammals. But just how these ancient fish used their ... evolutionary processes were at play remain scientific mysteries. , ... , turned to a living fish, called Polypterus , ... attempted to walk out of the water. Polypterus ...
(Date:8/27/2014)... is easier when it is related to ability that ... learn a new melody more easily than learning how ... the Center for the Neural Basis of Cognition (CNBC)a ... Mellon Universityhave discovered a fundamental constraint in the brain ... cover story in the Aug. 28, 2014, issue of ...
Breaking Biology News(10 mins):Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Walking fish reveal how our ancestors evolved onto land 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3
Other Contents